| |
| |
|
| Insider
Information: |
Kulkarni Samarth |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
208,122 |
|
|
Indirect Shares
|
200,000 |
|
|
| Direct
Value |
$11,090,821 |
|
|
|
Indirect Value
|
$10,658,000 |
|
|
| Total
Shares |
408,122 |
|
|
| Total
Value |
$21,748,821 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -85.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Crispr Therapeutics Ag |
CRSP |
|
2024-04-15 |
208,122 |
2024-04-15 |
200,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2024-04-15 |
4 |
AS |
$59.88 |
$1,173,232 |
D/D |
(19,582) |
208,122 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2024-04-15 |
4 |
OE |
$19.12 |
$374,408 |
D/D |
19,582 |
227,704 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2024-03-15 |
4 |
AS |
$71.97 |
$1,449,628 |
D/D |
(20,000) |
208,122 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2024-03-15 |
4 |
OE |
$19.12 |
$382,400 |
D/D |
20,000 |
228,122 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2024-03-12 |
4 |
S |
$74.44 |
$341,159 |
D/D |
(4,583) |
208,122 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2024-03-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,000 |
212,705 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2024-03-11 |
4 |
S |
$78.26 |
$767,105 |
D/D |
(9,802) |
203,705 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2024-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,250 |
213,507 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2024-02-20 |
4 |
S |
$79.67 |
$507,498 |
D/D |
(6,370) |
194,257 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2024-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,250 |
200,627 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2024-02-15 |
4 |
OE |
$19.12 |
$382,400 |
D/D |
20,000 |
207,377 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2024-02-15 |
4 |
AS |
$79.94 |
$1,607,177 |
D/D |
(20,000) |
187,377 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2024-01-29 |
4 |
AS |
$60.50 |
$3,025,573 |
D/D |
(50,000) |
187,377 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2024-01-29 |
4 |
OE |
$19.12 |
$956,000 |
D/D |
50,000 |
237,377 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2024-01-16 |
4 |
AS |
$62.50 |
$1,250,058 |
D/D |
(20,000) |
187,377 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2024-01-16 |
4 |
OE |
$19.12 |
$382,400 |
D/D |
20,000 |
207,377 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2023-05-30 |
4 |
OE |
$19.12 |
$478,000 |
D/D |
25,000 |
412,377 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2023-05-30 |
4 |
AS |
$63.61 |
$1,621,894 |
D/D |
(25,000) |
387,377 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2023-04-25 |
4 |
AS |
$50.50 |
$1,266,638 |
D/D |
(25,000) |
387,377 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2023-04-25 |
4 |
OE |
$19.12 |
$478,000 |
D/D |
25,000 |
412,377 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2023-03-13 |
4 |
D |
$43.22 |
$408,170 |
D/D |
(9,444) |
387,377 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2023-03-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,000 |
391,463 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2023-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,833 |
387,821 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2023-02-27 |
4 |
AS |
$47.71 |
$1,206,243 |
D/D |
(25,000) |
375,988 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2023-02-27 |
4 |
OE |
$19.12 |
$478,000 |
D/D |
25,000 |
400,988 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
